Literature DB >> 25994604

TLR4 as a possible key regulator of pathological vascular remodeling by Ang II receptor activation.

Kouichi Tamura1, Tomohiko Kanaoka1, Ryu Kobayashi1, Kohji Ohki1, Masato Ohsawa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25994604     DOI： 10.1038/hr.2015.65

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  19 in total

1.  Notch activation mediates angiotensin II-induced vascular remodeling by promoting the proliferation and migration of vascular smooth muscle cells.

Authors:  Yukako Ozasa; Hiroshi Akazawa; Yingjie Qin; Kaoru Tateno; Kaoru Ito; Yoko Kudo-Sakamoto; Masamichi Yano; Chizuru Yabumoto; Atsuhiko T Naito; Toru Oka; Jong-Kook Lee; Tohru Minamino; Toshio Nagai; Yoshio Kobayashi; Issei Komuro
Journal:  Hypertens Res       Date:  2013-05-30       Impact factor: 3.872

2.  TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase.

Authors:  Tadaaki Nakashima; Seiji Umemoto; Koichi Yoshimura; Susumu Matsuda; Shinichi Itoh; Tomoaki Murata; Tohru Fukai; Masunori Matsuzaki
Journal:  Hypertens Res       Date:  2015-04-09       Impact factor: 3.872

3.  Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension.

Authors:  T Fukai; M R Siegfried; M Ushio-Fukai; K K Griendling; D G Harrison
Journal:  Circ Res       Date:  1999-07-09       Impact factor: 17.367

Review 4.  Vascular effects of antihypertensive drug therapy.

Authors:  Asia Rehman; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 5.  Toll like receptor 4 in atherosclerosis and plaque destabilization.

Authors:  Wijnand K den Dekker; Caroline Cheng; Gerard Pasterkamp; Hencricus J Duckers
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

6.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

Authors:  Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 7.  Inflammation in hypertension.

Authors:  Carmine Savoia; Ernesto L Schiffrin
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-03       Impact factor: 2.894

8.  Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production.

Authors:  Isha Dhande; Wanshu Ma; Tahir Hussain
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

9.  Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.

Authors:  Takashige Kuwabara; Kiyoshi Mori; Masato Kasahara; Hideki Yokoi; Hirotaka Imamaki; Akira Ishii; Kenichi Koga; Akira Sugawara; Shinji Yasuno; Kenji Ueshima; Takashi Morikawa; Yoshio Konishi; Masahito Imanishi; Akira Nishiyama; Kazuwa Nakao; Masashi Mukoyama
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

10.  Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production.

Authors:  Priscila R De Batista; Roberto Palacios; Angela Martín; Raquel Hernanz; Cindy T Médici; Marito A S C Silva; Emilly M Rossi; Andrea Aguado; Dalton V Vassallo; Mercedes Salaices; María J Alonso
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240
View more
  1 in total

Review 1.  Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect.

Authors:  Antonios Lazaridis; Eleni Gavriilaki; Stella Douma; Eugenia Gkaliagkousi
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.